Combined synopsis and solicitation
Evaluating the utility of bulk RNA transcriptomics
FDA-CDER-25-128751
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$99,900.00 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2025
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Quantitative Analysis of Longitudinal MR Images
National Institutes of Health, National Institutes of Health Olao
Sources soughtNAICS 541714Bethesda, MD75N98027R00005Closes in 8 daysNov 9 - RFI Lupus Research Program (LRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027LRPCloses in 15 daysNov 16 - RFI Alzheimer’s Research Program (AZRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027AZRPCloses in 33 daysDec 4
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
The objective of this contract is to obtain service required to complete bulk transcriptomics of RNAs from treated and untreated primary liver hepatocytes. Transcriptomics data generated from bulk RNA sequencing will identify changes occurring for both coding and noncoding RNAs in primary human hepatocytes (PHHs) following treatment. Obtain the service required to complete bulk RNA sequencing or transcriptomics from treated primary liver hepatocytes (PHHS). Transcriptomics data generated from bulk RNA sequencing will quantify expression of both coding and noncoding RNAs in PHHs.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Seqmatic, LLC
- UEI
- T8LRGLKLMMT3
- CAGE
- 6SL88
- Vendor location
- Fremont, CA
- Contract
- 75F40125P00213, purchase order
- Obligated
- $99,900.00
- Actions
- 2 between September 4, 2025 and May 8, 2026
- Competition
- Competed Under SAP, 3 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Purchase of Next Generation Sequencing (Ngs) Rna Reagents Tests
- Match
- solicitation number FDACDER25128751 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 2, 2025
Combined synopsis and solicitation
Due July 16, 2025 at 3:00 PM EDT. SAM.gov, notice ebd4756deaef4990a822e050082eaf7f
July 7, 2025
Combined synopsis and solicitation
Due July 16, 2025 at 3:00 PM EDT. SAM.gov, notice b639aaad194147b7a262d331ccdeaedc
July 10, 2025
Combined synopsis and solicitation
Due July 16, 2025 at 3:00 PM EDT. SAM.gov, notice 52d1a274ef7e459c8a725f14f01a5048
Points of contact
- Rodney D. Aytchrodney.aytch@fda.hhs.gov2404027515